Global Blood Plasma Industry Report: 2014 Edition adds "Global Blood Plasma Market" report to its research store.

Increasing incidence of bleeding disorders across the globe has kept the global blood plasma market afloat and is likely to keep the momentum going on in near future as well. Major bleeding disorders, including Hemophilia A & B and Von Willebarnd disease, have been registering increasing number of patients across geographies which translates into expanding patient-base for the market. The industry has been on a transitional course wherein it is emerging from an industry deriving most of its revenues from the relatively smaller population of its traditional (read developed) markets to an industry witnessing a shift towards the emerging markets under similar perspective.

As per the report, Global Blood Plasma Market Report: 2014 Edition, rising healthcare expenditure, increasing penetration of plasma-derived products, ageing population, improving economic conditions and rising inclination of the developing world towards this industry, both in terms of rising demand and increasing domestic market access, have paved a concrete growth path for the industry. Furthermore, China still remains part of the unchartered waters that the industry hasn’t yet explored which adds to the optimism surrounding the future of the industry. However, increasing global fractionation capacities packed with already escalating price pressures and stricter regulation are likely to pose as the major hurdles on the same growth path.

This report presents an exhaustive study of the blood plasma market elucidating global market dynamics with an eye on major segments of the same. Major consumer countries of various plasma-proteins have also been discussed to complete the demand side of the industry. The report shines light on the major players that are shaping the industry: their market standing and business strategies against the backdrop of overall competitive landscape of the industry which have also been presented.

The report also encompasses the major trends, growth drivers as well as issues being faced by the global industry. Recent as well as future developments affecting the industry have also been presented. By deploying SPSS Inc.’s data integration and analysis capabilities, future growth prediction in terms of value of the industry has also been analyzed in the report.

Purchase a copy of this report @

Major points from Table of Contents ( are listed below:

List of Tables

Constituents of Blood Plasma

Recovered plasma vs. Source plasma

Output per Liter of Plasma

US Medicare IG Reimbursement Rates

A1PI Products

Long Acting FIX & FVIII under Late-Stage Development

Extended Half Life rFVIII Agents

Extended Half Life rFIX Agents

Global Fractionation Capacity and Throughput, 2014E

New Patient Registrations in the Worldwide Bleeding Disorders Market (2008-2013E)

Global Availability of NMEs (2012)

rFVIII Product Pipeline

Global Plasma Product Sales by Company (2010-2013)

Global Ig Sales by Company (2010-2013)

Dependent & Independent Variables (2007-2013)

Correlation Matrix

Model Summary - Coefficient of Determination

Regression Coefficients Output

Related Report on Medical Devices Market:

Global Endoscopy Market Report: 2014 Edition ( The development of technologically advanced endoscopic equipments in the US, Europe and Japan has resulted in steep market growth of endoscopic products in these regions, while diffusion of these products in emerging countries like China and India has just started. However, these emerging economies hold great opportunities for endoscopy market growth due to increasing income levels and improving medical infrastructure.

About Us:

MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.


Mr. Ritesh Tiwari

Corporate Office

TX, Dallas North - Dominion Plaza,

17304, Preston Road,

Suite 800, Dallas 75252.

Tel: + 1 888 391 5441